Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Baird Maintains Neutral on Quest Diagnostics, Raises Price Target to $154

Baird Maintains Neutral on Quest Diagnostics, Raises Price Target to $154

Baird analyst Eric Coldwell maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $143 to $154.

byBenzinga Newsdesk

January 12, 2023

1 minute read

Baird analyst Eric Coldwell maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $143 to $154.

Analyst Ratings

Expert Ratings for Williams-Sonoma

By Benzinga Insights

November 13, 8:00 AM

Analysts have provided the following ratings for Williams-Sonoma (NYSE:WSM) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

WSM

Why Is Apple Stock Sliding Tuesday?

By Anusuya Lahiri

January 2, 11:40 AM

Apple Inc (NASDAQ: AAPL) stock is trading lower Tuesday after Barclays analyst Tim Long downgraded the stock from Equal-Weight to Underweight and lowered the price target

AAPL

Why Is CarLotz Higher By More Than 30%: Here Are 28 Stocks Moving Premarket

By Lisa Levin

August 10, 6:08 AM

Gainers ObsEva SA (NASDAQ: OBSV) shares rose 33.8% to $0.4080 in pre-market trading. ObsEva recently announced a $31 million debt retirement and $11 million debt refinancing.

ABCL